Martindale Pharma has signed a multi-year exclusive manufacturing agreement with Burton Hospitals NHS Foundation Trust, with the latter supplying a number of Martindale’s specialty generic products including bismuth iodoform paraffin paste (BIPP) and lidocaine and phenylephrine topical solution, both routine treatments in ear nose and throat (ENT) surgery. Financial terms were not disclosed.

“This news follows two years of collaborative work with the Burton Hospital, one of our best performing contract manufacturing partners,” said Michael Clark, chief marketing officer, Martindale Pharma. “We believe this new agreement demonstrates how pharmaceutical companies can support NHS manufacturing units and offer patients the best drugs currently available on the market.”

Martindale Pharma has maintained a close partnership with NHS manufacturing units over the years, as well as supporting NHS staff with training. For the past six years, Martindale Pharma has worked with the UCL School of Pharmacy and London North West Healthcare NHS Trust’s Q3P Qualified Person (QP) Training Course providing academic and practical training to NHS qualified person trainees. As part of the course the pharmaceutical packaging module is hosted annually at Martindale Pharma’s Romford facility.

“We are very pleased to be able to share our expertise and knowledge in the manufacturing industry with trainee QPs and NHS manufacturing units,” said Mr. Clark. “Our expertise, combined with our modern, upgraded UK manufacturing facility not only allows us to manufacture high quality medicines efficiently, but supply these to a wide range of countries and health care systems, notably the UK where we have over 100 different products on contract to supply the UK NHS.”